Anna-Kaisa Ruotsalainen
Postdoctoral Researcher
Postdoctoral researcher
A.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences
anna-kaisa.ruotsalainen@uef.fi
Novel genetic atherosclerosis risk factors and future therapeutic targets in CVD.
Research groups
Publications
18/18 items-
Deletion of the Murine Ortholog of the Human 9p21.3 Locus Leads to Insulin Resistance and Obesity in Hypercholesterolemic Mice
Kettunen, Sanna; Suoranta, Tuisku; Beikverdi, Sadegh; Heikkilä, Minja; Slita, Anna; Räty, Iida; Ylä-Herttuala, Elias; Öörni, Katariina; Ruotsalainen, Anna-Kaisa; Ylä-Herttuala, Seppo. 2024. Cells. 13: A1 Journal article (refereed), original research -
Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity
Kettunen, Sanna; Ruotsalainen, Anna-Kaisa; Örd, Tiit; Suoranta, Tuisku; Heikkilä, Janne; Kaikkonen, Minna U.; Laham-Karam, Nihay; Ylä-Herttuala, Seppo. 2023. Frontiers in cardiovascular medicine. 10: . 1113890 A1 Journal article (refereed), original research -
Genetic variation is a key determinant of chromatin accessibility and drives differences in the regulatory landscape of C57BL/6J and 129S1/SvImJ mice
Mononen, Juho; Taipale, Mari; Malinen, Marjo; Velidendla, Bharadwaja; Niskanen, Einari; Levonen, Anna-Liisa; Ruotsalainen, Anna-Kaisa; Heikkinen, Sami. 2023. Nucleic acids research. 2024; 52: 2904-2923 A1 Journal article (refereed), original research -
Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 Mice
Koponen, Markus; Rysä, Jaana; Ruotsalainen, Anna-Kaisa; Kärkkäinen, Olli; Juvonen, Risto O. 2023. Journal of nutrition and metabolism. 2023: A1 Journal article (refereed), original research -
RNA interference-based therapies for the control of atherosclerosis risk factors
Kettunen, Sanna; Ruotsalainen, Anna-Kaisa; Ylä-Herttuala, Seppo. 2022. Current opinion in cardiology. 37: 364-371 A2 Review article, Literature review, Systematic review -
Menaquinone 4 increases plasma lipid levels in hypercholesterolemic mice
Weisell, Jonna; Ruotsalainen, Anna-Kaisa; Näpänkangas, Juha; Jauhiainen, Matti; Rysä, Jaana. 2021. Scientific reports. 11: 3014 A1 Journal article (refereed), original research -
Novel RNAi-Based Therapies for Atherosclerosis
Ruotsalainen, Anna-Kaisa; Mäkinen, Petri; Ylä-Herttuala, Seppo. 2021. Current atherosclerosis reports. 23: 45 A2 Review article, Literature review, Systematic review -
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice
Gurzeler, Erika; Ruotsalainen, Anna-Kaisa; Laine, Anssi; Valkama, Teemu; Kettunen, Sanna; Laakso, Markku; Ylä-Herttuala, Seppo. 2021. PLoS ONE. 16: e025840 A1 Journal article (refereed), original research -
LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight from Mouse Models
Cedo, Lidia; Metso, Jari; Santos, David; García-León, Annabel; Plana, Nuria; Sabate-Soler, Sonia; Rotllan, Noemi; Rivas-Urbina, Andrea; Mendez-Lara, Karen A; Tondo, Mireia; Girona, Josefa; Julve, Josep; Pallarès, Victor; Benitez-Amado, Aleyda; Llorente Cortes, Vicenta; Pérez, Antonio; Gómez-Coronado, Diego; Ruotsalainen, Anna-Kaisa; Levonen, Anna-Liisa; Sanchez-Quesada, Jose Luis et al.. 2020. Circulation research. 127: 778-792 A1 Journal article (refereed), original research -
Nucleic Acid-Based Therapies for Atherosclerosis
Mäkinen, P; Ruotsalainen, AK; Ylä-Herttuala, S. 2020. Current atherosclerosis reports. 22: 10 A2 Review article, Literature review, Systematic review